Sage Journals: Discover world-class research

Retricted access

Research article

First published 2026-1

The Efficacy and Safety of Intravitreal Aflibercept 8 mg in Clinical Practice

Brandon A. Bates, Hana A. Mansour, Hasenin Al-khersan [...]

Journal of VitreoRetinal Diseases

Open access

Review article

First published 2025

Plain language summary of publication of the 48-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edema

David M. Brown, David S. Boyer, Diana V. Do [...]

Therapeutic Advances in Ophthalmology

Open access

Review article

First published 2025

Plain language summary of publication of the 48-week results from the PULSAR study investigating how well a new dose of aflibercept works and how safe it is for people with wet age-related macular degeneration

Paolo Lanzetta, Jean-François Korobelnik, Jeffrey S. Heier [...]

Therapeutic Advances in Ophthalmology

Retricted access

Research article

First published 2012-12

Evaluation of Very High- and Very Low-Dose Intravitreal Aflibercept in Patients with Neovascular Age-Related Macular Degeneration

Quan Dong Nguyen, Peter A. Campochiaro, Syed Mahmood Shah [...]

Journal of Ocular Pharmacology and Therapeutics

Open access

Research article

First published 2023-1

Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial

Jeffrey S. Heier, Allen C. Ho, David S. Boyer [...]

Journal of VitreoRetinal Diseases

Open access

Review article

First published 2013

Review of Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration

Michael W. Stewart

Clinical Medicine Insights: Therapeutics

Retricted access

Research article

First published 2026

Comparison of Short-term Outcomes Between Faricimab and High-Dose Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Mizuho Shiratori, Maiko Maruyama-Inoue, Yasuo Yanagi [...]

Journal of VitreoRetinal Diseases

Retricted access

Research article

First published 2023-04

Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes

Shumpei Obata, Masashi Kakinoki, Osamu Sawada [...]

Journal of Ocular Pharmacology and Therapeutics

Retricted access

Editorial

First published 2025-5

“Triple and Plan” (TriPla) regimen for long lasting new generation intravitreal anti-VEGF

Federico Beretta, Riccardo Sacconi, Lea Querques [...]

European Journal of Ophthalmology

Retricted access

Review article

First published 2026-1

Assessing Long-Term Feasibility and Efficacy of Treatments for Retinal Vein Occlusion Macular Edema: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials

Tiago N.O. Rassi, Dillan Cunha Amaral, Eduardo Mund [...]

Journal of Ocular Pharmacology and Therapeutics

Search results